drugset / Trial / NCT04090047

A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants

NCT04090047

Phase 1 Completed 12 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelBasic science

Summary

An open-label, fixed-sequence, 2-period study to investigate the effect of multiple oral doses of itraconazole on a single oral dose of PF-06700841 PK in healthy participants. The study will consist of two treatment periods in one fixed sequence.

Timeline

Start
2019-09-24
Primary completion
2019-12-19
Completion
2019-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Brepocitinib Small molecule 30 mg Oral
Subject Itraconazole Small molecule 200 mg Oral

Indications

No indication recorded.